VANCOUVER, British Columbia, Aug. 30, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health Canada to produce natural, scalable, and accessible psychedelic and functional mushrooms for transformational human experiences, is pleased to announce that it has entered into its first international…

Source

Previous articleBright Minds Biosciences Announces Closing of $4 Million Unit Offering
Next articleNuminus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022